Pursuit Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Pursuit Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$483K	Buy	+8,955	New	+$431K	0.42%	86

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Pursuit Wealth Management's BMY Position: Q4 2025 in Review

Pursuit Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2025: 8,955 shares worth $483K. The stake represents 0.42% of the portfolio and ranks #86 among its holdings.

2,449 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Pursuit Wealth Management held 8,955 shares of Bristol-Myers Squibb worth $483K as of Q4 2025.
Bristol-Myers Squibb was a new Pursuit Wealth Management position in Q4 2025.
Bristol-Myers Squibb made up 0.42% of Pursuit Wealth Management's portfolio in Q4 2025, its #86 holding.
2,449 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Pursuit Wealth Management's 13F filing for Q4 2025, filed 26 Jan 2026.